Cargando…

581. COVID-19 Vaccine Perceptions in Adults from Greater Nashville Tennessee

BACKGROUND: In December 2020, SARS-CoV-2 vaccines were made available to healthcare workers and soon thereafter offered to the general public according to age and risk of severe illness. Despite widespread access, vaccination rates vary by region, with Tennessee ranking lower than the national avera...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernandez, Kailee N, Rankin, Danielle A, Howe, Harrison L, Bloos, Sean M, Salib, Seifein, Talj, Rana, Rahman, Herdi Kurnia, Waqfi, Danya, Villarreal, Jessica, Yanis, Ahmad, Howard, Leigh, Chappell, James, Halasa, Natasha B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644308/
http://dx.doi.org/10.1093/ofid/ofab466.779
_version_ 1784610055378698240
author Fernandez, Kailee N
Rankin, Danielle A
Howe, Harrison L
Bloos, Sean M
Salib, Seifein
Talj, Rana
Rahman, Herdi Kurnia
Waqfi, Danya
Villarreal, Jessica
Yanis, Ahmad
Howard, Leigh
Chappell, James
Halasa, Natasha B
Halasa, Natasha B
author_facet Fernandez, Kailee N
Rankin, Danielle A
Howe, Harrison L
Bloos, Sean M
Salib, Seifein
Talj, Rana
Rahman, Herdi Kurnia
Waqfi, Danya
Villarreal, Jessica
Yanis, Ahmad
Howard, Leigh
Chappell, James
Halasa, Natasha B
Halasa, Natasha B
author_sort Fernandez, Kailee N
collection PubMed
description BACKGROUND: In December 2020, SARS-CoV-2 vaccines were made available to healthcare workers and soon thereafter offered to the general public according to age and risk of severe illness. Despite widespread access, vaccination rates vary by region, with Tennessee ranking lower than the national average. Therefore, we aimed to survey adults in greater Nashville, TN regarding SARS-CoV-2 vaccine perceptions. METHODS: We conducted a cross-sectional study of an ongoing longitudinal cohort of individuals with confirmed and/or suspected SARS-CoV-2 infection and their household contacts with enrollment onset in March 2020. For this analysis, individuals were included if they were ≥ 18 years and available for a one-year follow-up visit. At the one-year visit individuals completed a survey about vaccine preferences, beliefs and risks. Demographic and social characteristics were collected at enrollment. Individuals were considered vaccinated if they had received at least one dose of a SARS-CoV-2 vaccine under FDA emergency use authorization. Vaccine perceptions were compared by SARS-CoV-2-infection and vaccination status using Pearson’s chi-squared, alpha=5%. RESULTS: Between April-May 2021, 115 individuals completed the one-year follow-up. Table 1 includes sociodemographic characteristics of adults, of which the majority were vaccinated and were unemployed or in non-essential occupations. Most individuals agreed the SARS-CoV-2 vaccine can prevent infection and hospitalization (Figure 1A & B). Unvaccinated participants more often agreed that those who contracted SARS-CoV-2 should not receive the vaccine (30%), whereas vaccinated persons less often agreed (11%, p< 0.001) (Figure 1A). Additionally, 44% of unvaccinated individuals were neutral or disagreed that benefits of SARS-CoV-2 vaccination outweighed the illness risk, compared to 10% in the vaccinated group, p=0.001 (Figure 1A). Minimal differences of vaccine perceptions were observed between SARS-CoV-2 positive and negative adults (Figure 1B). Table 1. Sociodemographic Characteristics of Adults [Image: see text] Figure 1. Vaccine perceptions of vaccinated and unvaccinated (A) SARS-CoV-2 positive and SARS-CoV-2 negative (B) adults in greater Nashville, TN. Vaccine perceptions were collected through a standardized survey at the one-year visit. [Image: see text] CONCLUSION: Although some unvaccinated individuals seemingly perceived the SARS-CoV-2 vaccine offered some protection, research should continue to evaluate the implications of vaccine hesitancy on the COVID-19 pandemic response as we prepare for the upcoming respiratory season. DISCLOSURES: Natasha B. Halasa, MD, MPH, Genentech (Other Financial or Material Support, I receive an honorarium for lectures - it's a education grant, supported by genetech)Quidel (Grant/Research Support, Other Financial or Material Support, Donation of supplies/kits)Sanofi (Grant/Research Support, Other Financial or Material Support, HAI/NAI testing) Natasha B. Halasa, MD, MPH, Genentech (Individual(s) Involved: Self): I receive an honorarium for lectures - it's a education grant, supported by genetech, Other Financial or Material Support, Other Financial or Material Support; Sanofi (Individual(s) Involved: Self): Grant/Research Support, Research Grant or Support
format Online
Article
Text
id pubmed-8644308
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-86443082021-12-06 581. COVID-19 Vaccine Perceptions in Adults from Greater Nashville Tennessee Fernandez, Kailee N Rankin, Danielle A Howe, Harrison L Bloos, Sean M Salib, Seifein Talj, Rana Rahman, Herdi Kurnia Waqfi, Danya Villarreal, Jessica Yanis, Ahmad Howard, Leigh Chappell, James Halasa, Natasha B Halasa, Natasha B Open Forum Infect Dis Poster Abstracts BACKGROUND: In December 2020, SARS-CoV-2 vaccines were made available to healthcare workers and soon thereafter offered to the general public according to age and risk of severe illness. Despite widespread access, vaccination rates vary by region, with Tennessee ranking lower than the national average. Therefore, we aimed to survey adults in greater Nashville, TN regarding SARS-CoV-2 vaccine perceptions. METHODS: We conducted a cross-sectional study of an ongoing longitudinal cohort of individuals with confirmed and/or suspected SARS-CoV-2 infection and their household contacts with enrollment onset in March 2020. For this analysis, individuals were included if they were ≥ 18 years and available for a one-year follow-up visit. At the one-year visit individuals completed a survey about vaccine preferences, beliefs and risks. Demographic and social characteristics were collected at enrollment. Individuals were considered vaccinated if they had received at least one dose of a SARS-CoV-2 vaccine under FDA emergency use authorization. Vaccine perceptions were compared by SARS-CoV-2-infection and vaccination status using Pearson’s chi-squared, alpha=5%. RESULTS: Between April-May 2021, 115 individuals completed the one-year follow-up. Table 1 includes sociodemographic characteristics of adults, of which the majority were vaccinated and were unemployed or in non-essential occupations. Most individuals agreed the SARS-CoV-2 vaccine can prevent infection and hospitalization (Figure 1A & B). Unvaccinated participants more often agreed that those who contracted SARS-CoV-2 should not receive the vaccine (30%), whereas vaccinated persons less often agreed (11%, p< 0.001) (Figure 1A). Additionally, 44% of unvaccinated individuals were neutral or disagreed that benefits of SARS-CoV-2 vaccination outweighed the illness risk, compared to 10% in the vaccinated group, p=0.001 (Figure 1A). Minimal differences of vaccine perceptions were observed between SARS-CoV-2 positive and negative adults (Figure 1B). Table 1. Sociodemographic Characteristics of Adults [Image: see text] Figure 1. Vaccine perceptions of vaccinated and unvaccinated (A) SARS-CoV-2 positive and SARS-CoV-2 negative (B) adults in greater Nashville, TN. Vaccine perceptions were collected through a standardized survey at the one-year visit. [Image: see text] CONCLUSION: Although some unvaccinated individuals seemingly perceived the SARS-CoV-2 vaccine offered some protection, research should continue to evaluate the implications of vaccine hesitancy on the COVID-19 pandemic response as we prepare for the upcoming respiratory season. DISCLOSURES: Natasha B. Halasa, MD, MPH, Genentech (Other Financial or Material Support, I receive an honorarium for lectures - it's a education grant, supported by genetech)Quidel (Grant/Research Support, Other Financial or Material Support, Donation of supplies/kits)Sanofi (Grant/Research Support, Other Financial or Material Support, HAI/NAI testing) Natasha B. Halasa, MD, MPH, Genentech (Individual(s) Involved: Self): I receive an honorarium for lectures - it's a education grant, supported by genetech, Other Financial or Material Support, Other Financial or Material Support; Sanofi (Individual(s) Involved: Self): Grant/Research Support, Research Grant or Support Oxford University Press 2021-12-04 /pmc/articles/PMC8644308/ http://dx.doi.org/10.1093/ofid/ofab466.779 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Abstracts
Fernandez, Kailee N
Rankin, Danielle A
Howe, Harrison L
Bloos, Sean M
Salib, Seifein
Talj, Rana
Rahman, Herdi Kurnia
Waqfi, Danya
Villarreal, Jessica
Yanis, Ahmad
Howard, Leigh
Chappell, James
Halasa, Natasha B
Halasa, Natasha B
581. COVID-19 Vaccine Perceptions in Adults from Greater Nashville Tennessee
title 581. COVID-19 Vaccine Perceptions in Adults from Greater Nashville Tennessee
title_full 581. COVID-19 Vaccine Perceptions in Adults from Greater Nashville Tennessee
title_fullStr 581. COVID-19 Vaccine Perceptions in Adults from Greater Nashville Tennessee
title_full_unstemmed 581. COVID-19 Vaccine Perceptions in Adults from Greater Nashville Tennessee
title_short 581. COVID-19 Vaccine Perceptions in Adults from Greater Nashville Tennessee
title_sort 581. covid-19 vaccine perceptions in adults from greater nashville tennessee
topic Poster Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644308/
http://dx.doi.org/10.1093/ofid/ofab466.779
work_keys_str_mv AT fernandezkaileen 581covid19vaccineperceptionsinadultsfromgreaternashvilletennessee
AT rankindaniellea 581covid19vaccineperceptionsinadultsfromgreaternashvilletennessee
AT howeharrisonl 581covid19vaccineperceptionsinadultsfromgreaternashvilletennessee
AT bloosseanm 581covid19vaccineperceptionsinadultsfromgreaternashvilletennessee
AT salibseifein 581covid19vaccineperceptionsinadultsfromgreaternashvilletennessee
AT taljrana 581covid19vaccineperceptionsinadultsfromgreaternashvilletennessee
AT rahmanherdikurnia 581covid19vaccineperceptionsinadultsfromgreaternashvilletennessee
AT waqfidanya 581covid19vaccineperceptionsinadultsfromgreaternashvilletennessee
AT villarrealjessica 581covid19vaccineperceptionsinadultsfromgreaternashvilletennessee
AT yanisahmad 581covid19vaccineperceptionsinadultsfromgreaternashvilletennessee
AT howardleigh 581covid19vaccineperceptionsinadultsfromgreaternashvilletennessee
AT chappelljames 581covid19vaccineperceptionsinadultsfromgreaternashvilletennessee
AT halasanatashab 581covid19vaccineperceptionsinadultsfromgreaternashvilletennessee
AT halasanatashab 581covid19vaccineperceptionsinadultsfromgreaternashvilletennessee